Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)

Brief description of study

Inflammatory Bowel Diseases (IBD) are treated with many different medications, none of which are 100% effective. One of the challenges of treating IBD is to identify the best therapy for the individual patient. The goals of this research are to identify new diagnostic tests that can predict which patient will respond to which treatment and who is most likely to relapse. In addition, data will be collected over many years that can be used to answer other questions related to IBD, such as identifying new targets for medications to treat IBD, determining patient characteristics that are associated with more or less severe disease, and developing new tools to measure inflammation related to IBD.

Clinical Study Identifier: s18-00559

Principal Investigator: David P Hudesman.

Other Investigators: Elie S Al Kazzi, Shannon Chang, Adam Faye, Simon J Hong, Ariela Holmer, Jordan E Axelrad, Bradley M. Morganstern.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies